BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//European Brain Council (EBC) - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.braincouncil.eu
X-WR-CALDESC:Events for European Brain Council (EBC)
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20250101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=UTC:20260224T090000
DTEND;TZID=UTC:20260224T160000
DTSTAMP:20260531T165612
CREATED:20251106T083026Z
LAST-MODIFIED:20260223T100758Z
UID:59399-1771923600-1771948800@www.braincouncil.eu
SUMMARY:Advancing the Rare Brain Disease Ecosystem
DESCRIPTION:24 February 2026 \nRare Disease Day 2026 Advancing the Rare Brain Disease Ecosystem This event will take place at BlankSpace Place du Luxembourg\, Rue d’Arlon 80\, 1040\, Brussels\, Belgium. \nThe main purpose of Rare Disease Day is to raise awareness about rare diseases and their impact on the lives of those affected. Building on the European Brain Council’s (EBC) ongoing work on rare diseases\, the Rare Brain Disease (RBD) Ecosystem was launched in 2025. This initiative aims to engage key stakeholders across Europe to identify gaps\, set priorities\, and foster collaborative projects\, with a focus on strengthening the integration of research and healthcare. Placing brain health at the core of rare disease prevention and management\, this event gathers multidisciplinary experts from research\, clinical care\, patient advocacy\, and industry to share perspectives and priorities on the rare disease research\, care\, and policy space. \nThe meeting will review recent European project and regulatory developments and discuss practical strategies to advance the RBD Ecosystem and build a comprehensive Knowledge Hub. Experts will also explore how care and treatment pathways for Myasthenia Gravis (MG)\, Neurofibromatosis Type-1\, and Childhood Dementia can be improved\, drawing on both patient and clinician perspectives. Highlights include the launch of the Rethinking MG Advocacy Paper and the announcement of a new Neurofibromatosis Type 1 project. \nProgrammeJoin Online
URL:https://www.braincouncil.eu/event/rare-disease-day-2026/
LOCATION:Brussels\, Belgium
CATEGORIES:RBDE,Rethinking MG,Rethinking NF1
ATTACH;FMTTYPE=image/png:https://www.braincouncil.eu/wp-content/uploads/2025/11/Website-Banner-Rare-Disease-Day-2026.png
ORGANIZER;CN="European Brain Council":MAILTO:advocacy@braincouncil.eu
END:VEVENT
END:VCALENDAR